However, complications following shunt surgery are common, 11,16 especially subdural hematoma (SDH) seen in 2%-21% of iNPH patients treated with VP or VA shunts. 7,8,15,21 Adjustable valves that permit the opening pressure to be changed externally have been recommended as a means of reducing the complication rate and enabling clinicians to optimize individual treatment.
1,2Randomized studies have indicated that lower opening pressure is related to better outcome 5 but also to more overdrainage symptoms, 6 SDH, and subdural effusions.
5,6Delwel et al. recommended that shunt treatment should beabbreviatioNs ASD = antisiphon device; BMI = body mass index; ICP = intracranial pressure; iNPH = idiopathic normal pressure hydrocephalus; ITT = intention-totreat; RCT = randomized controlled trial; SDH = subdural hematoma; SDS = standard deviation score (standardized score); tSDS = total SDS; VA = ventriculoatrial; VP = ventriculoperitoneal. obJective The study aim was to examine the effect of gradually reducing the opening pressure on symptoms and signs in the shunt treatment of idiopathic normal pressure hydrocephalus (iNPH). methods In this prospective double-blinded, randomized, controlled, double-center study on patients with iNPH, a ventriculoperitoneal shunt with an adjustable Codman Medos Valve was implanted in 68 patients randomized into 2 groups. In 1 group (the 20-4 group) the valve setting was initially set to 20 cm H 2 O and gradually reduced to 4 cm H 2 O over the course of the 6-month study period. In the other group (the 12 group), the valve was kept at a medium level of 12 cm H 2 O during the whole study period. All patients were clinically evaluated using 4 tests preoperatively as well as postoperatively at 1, 2, 3, 4, and 6 months. The test scores between the 2 groups (20-4 and 12) were compared for each clinical evaluation. results Fifty-five patients (81%) were able to complete the study. There were no significant differences between the 2 groups (20-4 and 12) preoperatively or at any time postoperatively. Both groups exhibited significant clinical improvement after shunt insertion at all valve settings compared with the preoperative score, with the greatest improvement observed at the first postoperative evaluation. The clinical improvement was significant within the first 3 months, and thereafter no significant improvement was seen in either group. coNclusioNs Gradual reduction of the valve setting from 20 to 4 cm H 2 O did not improve outcome compared with a fixed valve setting of 12 cm H 2 O. Improvement after shunt surgery in iNPH patients was evident within 3 months, irrespective of valve setting.